Welcome to ESWI's Education Hub.

Use the different filters or search button to find your preferred content.

๐Ÿ”Topics
๐Ÿ”Medium
๐Ÿ”Risk groups
๐Ÿ”Networks
  1. News,Scientific Papers
    Scientific highlights of the 9th ESWI Influenza Conference
    With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
    Read more
  2. News
    What to Know About the Bird Flu Outbreak in Dairy Cows
    The infections, which include one associated human case, add another worrying wrinkle to a global outbreak that has devastated bird and marine mammal populations.
    Read more
  3. News
    U.S. dairy farm worker infected as bird flu spreads to cows in five states
    Unexpected H5N1 outbreaks in cattle raise difficult questions about how to protect herds and people
    Read more
  4. News,Reports
    The Ninth ESWI Influenza Conference: Highlights
    ESWI 2023: 10 key take home messages
    Read more
  5. News,Scientific Papers
    H7N9 avian influenza virus infection in men is associated with testosterone depletion
    Human infections with H7N9 avian influenza A virus that emerged in East China in 2013 and caused high morbidity rates were more frequently detected in men than in women over the last five epidemic waves.
    Read more
  6. News,Scientific Papers
    Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons
    We observed the interference between two prevalent respiratory viruses, respiratory syncytial virus (RSV) and influenza A virus (IAV) (H1N1), and characterized its molecular underpinnings in alveolar epithelial cells (A549).
    Read more
  7. News,Scientific Papers
    Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
    Combined vaccine formulations targeting not only hemagglutinin but also other influenza virus antigens could form the basis for a universal influenza virus vaccine that has the potential to elicit long-lasting, broadly cross-reactive immune responses.
    Read more